We have redesigned cationic liposomes by using a combi-ODN (LE-ATG-AS) inhibited Raf-1 protein expression in nation of dimethyldioctadecyl ammonium bromide, phosvitro and in vivo. Furthermore, radioresistant tumor cells phatidylcholine and cholesterol to enhance the in vitro and treated with LE-ATG-AS raf ODN were sensitized to ionizin vivo effectiveness of antisense raf oligodeoxyribonucleoing radiation. These data provide new information for the tide (ODN). Circulating ODNs carried in vivo by liposomes delivery and potency of antisense ODN in vivo, and support were intact for at least 24 h, while free ODNs were undethe use of LE-ATG-AS raf ODN for gene therapy of radiotectable after 5 min. Liposome-encapsulated antisense raf resistant cancer.
Introduction tion pathways. [20] [21] [22] [23] [24] [25] [26] Antisense c-raf-1 cDNA transfection In recent years, antisense oligodeoxyribonucleotides of the radioresistant laryngeal squamous carcinoma cells (ODNs/oligos) have generated considerable interest as (SQ-20B) leads to a delayed growth of tumor cells in therapeutic agents for human viral diseases, inflammaathymic mice and enhanced radiosensitization. 27 Consisttory disorders and cancer. [1] [2] [3] The potency of ODNs with ent with these observations, antisense raf oligo-treated phosphodiester backbone is limited due to nuclease sen-SQ-20B tumor cells have demonstrated inhibition of Rafsitivity. 4, 5 Introduction of phosphorothioate linkages, 1 protein kinase activity and increased radiosensitizwhereby one of the nonbridging oxygens in the phosation. 28, 29 The antitumor activity of antisense raf S-oligo phodiester backbone is replaced with a sulfur, has been directed toward a part of the 3′-untranslated region has shown to confer nuclease resistance. 6 However, toxicity also been demonstrated. 30 These data support the use of studies of phosphorothioate oligos (S-oligos) have shown antisense raf oligos in cancer gene therapy. side-effects in animals and humans, perhaps due to the Initially, we demonstrated that antisense raf oligo, polyanionic nature of S-oligos. 7 Recent studies have directed towards the translation initiation site of human developed oligos with mixed-backbone or sugar-modic-raf-1 cDNA (ATG-AS raf ODN), inhibits Raf-1 protein fied nucleoside analogs. These second generation antikinase expression in SQ-20B cells. This inhibition corresense oligos are promising because of their more acceptlates with increased sensitivity of tumor cells to ionizing able biological and pharmacological properties. 8, 9 radiation. 31 However, a maximum inhibition of Raf-1 Efforts at developing methods to deliver therapeutic expression (approximately 40%) could be achieved when compounds effficiently have led to the use of liposomes cells were exposed to a nontoxic, but relatively high conas a carrier system. [10] [11] [12] [13] [14] [15] [16] [17] Cationic lipids have been shown centration of antisense raf oligo (100 m, 12 h). The aim to enhance the association of oligos with cells, and of the present study was to design cationic liposomes to increase the potency of antisense oligos in vitro. 18 Howdeliver the antisense raf oligo efficiently in vitro and in ever, the cellular binding and uptake of oligos complexed vivo. A related aim was to evaluate the effect of liposomewith certain cationic liposomes have been inhibited in the encapsulated antisense raf oligo on the radiation survival presence of serum or plasma. 19 The in vivo potency of response of tumor cells. antisense oligos using cationic liposomes has yet to be be elucidated.
Raf-1 protein kinase plays an important role in mito-DMTAP), phosphatidylcholine (PC), and cholesterol tendency to form small aggregates, which could be easily dispersed by gentle shaking. The ODN appeared to be (CHOL) in a molar ratio of 1:3.2:1.6 as described in Materials and methods. Initially, we determined the distributed in the lipid bilayers and aqueous spaces. We next compared the effects of blank liposomes (BL), lipo-ODN entrapment efficiency of liposomes by scintillation counting of an aliquot of the preparation in which traces some-encapsulated antisense (LE-ATG-AS) and sense (LE-ATG-S) raf ODNs on cell survival. Blank liposomes, of radiolabeled antisense (ATG-AS) or sense (ATG-S) raf ODN was added to the initial ODN. PC/CHOL/DDAB at a concentration equivalent to 10.0 m or less of LE-ATG-AS/S raf ODN were non-toxic as determined by the formulation yielded the maximum ODN entrapment efficiency (Ͼ90%, n = 10). PC/CHOL/DOTAP and clonogenic survival and trypan blue dye exclusion methods (data not shown). However, blank liposomes PC/CHOL/DMTAP liposomes were found to be highly cytotoxic. Therefore, the subsequent experiments were showed cytotoxicity at doses higher than 20 m and, therefore, doses of 10 m or less were used for the subperformed using the PC/CHOL/DDAB formulation of liposomes.
sequent in vitro studies. For in vivo studies, mice were intravenously (i.v.) treated with a daily dose of 6 mg/kg Fluorescence image analysis using fluorescein-labeled ATG-AS raf ODN was performed to visualize the encapblank liposomes for 2 weeks, and then monitored for the next 30 days. No signs of weight loss or discomfort were sulation of ODNs in liposomes. A heterogeneous size population of liposomes was obtained including relanoted, indicating that this liposomal formulation is nontoxic in vivo. tively large (Figure 1 ) and small liposomes (Ͻ2 microns, data not shown). In general, the liposomes showed a Liposomal encapsulation enhances raf ODN uptake in vitro and stability in vitro and in vivo We have previously demonstrated that Ͻ2% of the free ATG-AS raf ODN was taken up by SQ-20B cells at 6 h when exposed to 100 m concentration in the presence of low serum (1%), and the maximal uptake was approximately 4% at 12 h after treatment. 31 In the present study, we asked whether liposome encapsulation enhances the uptake and stability of ODN in tumor cells. The kinetics of cellular uptake of LE-ATG-AS raf ODN in the presence of 1% serum is shown in Figure 2a . The intracellular level of ODN increased over time, reaching a plateau 8 h after incubation. Approximately 13% of the total applied LE-ATG-AS raf ODN (10 m) was incorporated into the cells. These results demonstrate that a significant increase in the intracellular level of ODN was achieved when tumor cells were treated with a 10-fold lower concentration of LE-ATG-AS raf ODN as compared with free ATG-AS raf ODN.
To examine the intracellular stability of LE-ATG-AS raf ODN, 32 P-labeled ODN was recovered at various times following initial treatment of cells with radiolabeled LE-ATG-AS raf ODN (10 m) for 4 h. The integrity of the ODN was determined by denaturing gel electrophoresis as described in Materials and methods. Intact raf ODN (15-mer) was identified and no degradation was observed up to 24 h (Figure 2b ). In contrast, cells treated with an equimolar concentration of free ATG-AS raf ODN, showed no detectable ODN at all time-points (data not shown). In other studies, 15-mer ODN was intact following incubation of LE-ATG-AS raf ODN for 24 h in medium containing relatively high levels of serum (15% FBS) (data not shown). These results suggest that liposomal encapsulation protects raf ODN from serum nuclease-induced degradation.
The plasma pharmacokinetics of LE-ATG-AS raf ODN is shown in Figure 3 . Following i.v. administration, the peak plasma concentration of 6.39 g/ml was achieved and intact ODN could be detected up to 24 h. The decrease in plasma concentration of LE-ATG-AS raf ODN followed a biexponential pattern with an initial half-life (Figure 5a ). The inhibitory effect of LE-ATG-AS raf ODN (AS) was seen up to 24 h (45.6 ± 9.8%). The levels of Raf-1 protein were comparable in the control untreated cells (C), blank liposome-treated cells (BL), and LE-ATG-S raf ODN-treated cells (S) (Figure 5a We examined the effect of LE-ATG-AS raf ODN on the enzymatic activity of Raf-1 protein kinase using its physiological substrate, mitogen-activated protein kinase kinase (MKK1). 32 Raf-1 protein kinase activity was comparable in control, untreated cells and LE-ATG-S raf 1 cDNAs share a conserved nucleotide sequence in the translation initiation region (Leszek Woznowski, personal communication). Therefore, we examined the effect was detectable only at 5 min; with a plasma concentration of 9.75 g/ml. These observations are in agreement with of ATG-AS/S raf ODN on Raf-1 expression in normal mouse tissues. No inhibition of Raf-1 expression was the in vitro observations, and suggest that free ATG-AS raf ODN is rapidly degraded in plasma, whereas LEobserved in normal tissues following i.v. administration of free ATG-AS raf ODN (6 mg/kg, daily for 5 days) (data ATG-AS raf ODN is in circulation for up to 24 h.
The tissue distribution of LE-ATG-AS raf ODN is not shown). However, i.v. administration of the LE-ATG-AS raf ODN (6 mg/kg, daily for 5 days), but not LE-ATGshown in Figure 4 . Intact ODN was detected in all organs examined up to 48 h (Figure 4a ). Following the adminis-S raf ODN, led to a significant inhibition of Raf-1 (approximately 74 kDa) in liver (51.6 ± 17.4%; n = 3), and tration of free ATG-AS raf ODN, intact ODN was seen only at 5 min in various organs and degradative products kidneys (42.2 ± 11.0%; n = 3) ( Figure 7 ). LE-ATG-AS raf ODN-associated inhibition of Raf-1 did not occur in heart (Ͻ15-mer) were subsequently found (data not shown). Previous reports of the pharmacokinetic profiles of the and lungs (n = 3, data not shown). These observations are consistent with the normal tissue disposition profiles fully phosphorothioated ODNs (S-oligos), delivered without a carrier, suggest that liver and kidney are the of LE-ATG-AS raf ODN, showing a relatively higher accumulation of ODN in liver and kidneys compared preferential sites of ODN accumulation. 5 Our data are in agreement with these studies, however, the possibility with heart and lungs ( Figure 4b ). It remains to be seen whether inhibition of Raf-1 in liver and kidney is associaremains that liposomal delivery may have facilitated targeting of ODN to certain tissues, including liver and ted with any appreciable toxicities to these organs. 
Figure 3 The plasma concentration-time profile of LE-ATG-AS raf ODN. 30 mg/kg LE-ATG-AS raf ODN (top panel) or ATG-AS raf ODN (middle panel) was administered i.v. in Balb/c nu/nu mice. Blood samples were collected from retro-orbital sinus at indicated times after injection and the

Figure 4 Tissue distribution profiles of LE-ATG-AS raf ODN. Tissue samples were collected at indicated times after i.v. administration of 30 mg/kg LE-ATG-AS raf ODN. ODNs were extracted from homogenized tissues and probed with 32 P-labeled ATG-S raf ODN as explained in the experimental procedures. (a) Representative autoradiographs from liver and kidney. (b) ATG-AS raf ODN concentration in different tissues at indicated times after a dose of 30 mg/kg LE-ATG-AS raf ODN was administered i.v. Quantification data were calculated based on comparison with known concentrations of the standard samples, and then normalization against the weights of organs collected.
Figure 5 Specificity of inhibition of Raf-1 protein expression by LE-ATG-AS raf ODN. (a) Time-course analysis. Logarithmically growing SQ-20B cells were treated with 10 m of LE-ATG-AS raf ODN (AS), or LE-ATG-S raf ODN (S) for indicated times in 1% FBS containing medium. Untreated control cells (C) or cells treated with blank liposomes (10 m) were simultaneously switched to 1% FBS containing medium for 8 h. Whole cell lysates were normalized for total protein content and immunoprecipitated with agarose-conjugated polyclonal anti-Raf-1 antibody (Santa Cruz). Immune complexes were immunoblotted with polyclonal anti-Raf-1 antibody as described in the experimental procedures (top). Results from three independent experiments were quantified and data are expressed relative to the level of Raf-1 in LE-ATG-S raf ODN-treated cells (bottom). (b) Dose-response analysis. Logarithmically growing SQ-20B tumor cells were treated with indicated concentrations of LE-ATG-AS raf ODN (AS) or LE-ATG-S raf ODN (S) in 1% FBS containing medium for 8 h. Normalized cell lysates were analyzed for Raf-1 expression (top). Quantification data from three independent experiments are expressed relative to the level of Raf-1 in LE-ATG-S raf ODN-treated cells (bottom).
Surprisingly, i.v. treatment with LE-ATG-AS raf ODN blank liposomes are presented in Table 1 . The plating resulted in variable effects on Raf-1 expression in differefficiencies of cells treated with LE-ATG-S/AS raf ODN ent SQ-20B tumor xenografts, with levels of inhibition or blank liposomes were comparable ( Table 1 ). The ranging from 37.6 to 57.6% compared with LE-ATG-S raf single-hit, multitarget (target model) and the linear quad-ODN-treated tumor xenografts (n = 3) (Figure 7 ). We ratic model (LQ) are most commonly used to analyze interpret this to be due to differences in tumor vasculatcellular radiation survival. The target model is based on ure in different xenografts, impeding the delivery of the parameters D 0 and n , where D 0 is the inverse of the ODN to poorly perfused tumor sites. Intravenous treatterminal slope of the survival curve and n is the extrapolment with free ATG-AS/S raf ODN, LE-ATG-S raf ODN ation of this slope to the ordinate. 33 The higher the D 0 (S) , blank liposomes, or normal saline (C) had no effect value, the more resistant are cells to radiation-induced on Raf-1 expression in tumor tissue compared with cell killing. Another parameter, D q is the measure of the untreated controls. Variations in the level of Raf-1 inhishoulder of the survival curve as the terminal slope line bition observed after i.v. treatment prompted us to invesintersects the abscissa. 34 The LQ model has two major tigate the effect of intratumoral administration of LEparameters: ␣, the linear component characterizing the ATG-AS raf ODN or LE-ATG-S raf ODN on Raf-1 radiation response at lower doses; and ␤, the quadratic expression. Results shown in Figure 8 demonstrate a sigcomponent characterizing the response at higher doses. nificant inhibition of Raf-1 protein expression in SQ-20B
The higher the value of ␣, the more sensitive are the cells tumor xenografts following intratumoral treatment with to radiation. 35 A model-free parameter, D is called the LE-ATG-AS raf ODN compared with LE-ATG-S raf ODN mean inactivation dose and represents the area under the (60.3 ± 6.4%; n = 3). Taken together, these data demonsurvival curve plotted on linear coordinates. 29, 36 Clonostrate that LE-ATG-AS raf ODN inhibits Raf-1 expression genic cell survival data were computer-fitted to the in a sequence-specific manner in vivo. effectively. Based on fluorescence microscopy, it appears that oligos may be entrapped inside the lipid bilayer ( Figure 1 ). These observations extend the initial reports that showed encapsulation of plasmid DNA within lipid sheets or tubes. 38,39 By simultaneously measuring plasma and tissue levels, we also demonstrate that liposomal encapsulation of oligos protects these relatively small pieces of DNA from degradation in plasma and facilitates their tissue accumulation (Figures 3 and 4) . Circulating antisense raf oligos carried in vivo by liposomes were intact for at least 24 h, while free oligos were undetectable after 5 min. These data are in agreement with previous reports showing that phosphodiester oligos with only two terminal phosphorothioate linkages at the 3′ and 5′ ends resemble the unblocked phosphodiester oligos, and that these oligos are rapidly cleared from the blood and show little tissue accumulation. 40 As mentioned earlier, the use of PC along with cholesterol in our liposomal preparation may have facilitated the prolonged retention of oligos in the circulation, as well as tissue disposition and stability of oligos.
Particle size has been shown to play a major role in liposome biodistribution and the route of cell entry.
Figure 6 Inhibition of Raf-1 protein kinase activity by LE-ATG-AS raf
Larger liposomes are distributed primarily to the reticul-
ODN. Logarithmically growing SQ-20B cells were treated with 10 m
oendothelial system with negligible amounts in other cationic liposomes, approximately 2.0 microns in diameter, are transiently taken up by the lungs followed by rapid distribution to liver. Recent studies demonstrated that endocytosis is the principal pathway for delivery of antisense sequence-specific inhibition of Raf-1 protein oligonucleotides via cationic liposomes. 42 Our liposomal kinase and radiosensitization. Based on a ratio of the preparations consisted of both large and small liposomes. mean inactivation dose, the dose modifying factor (DMF) Consistent with the above notion, we demonstrate that of LE-ATG-AS raf ODN treatment (10 m) was approxithe clearance of LE-ATG-AS raf ODN followed a biphasic mately 1.6. These data are significant because a 10-fold pattern with preferential distribution to liver. higher concentration of the free ATG-AS raf ODN is Liposome-encapsulated antisense raf oligos were nonrequired to achieve a comparable level of the radiosensittoxic, and inhibited Raf-1 expression in vitro and in vivo ization of SQ-20B cells (ATG-AS raf ODN, 100 m; DMF in a sequence-specific manner ( Figures 5-8 and Table 1 ). approximately 1.4). 31 It is noteworthy that intravenous and intratumoral routes Cationic liposomes have been used for in vivo delivery of LE-ATG-AS raf ODN administration led to a signifiof relatively large fragments of DNA. 12, 13, 15 Recent studies cant inhibition of Raf-1 expression in SQ-20B tumor showed that the cationic liposome formulation of DOTIM tissue, suggesting the potential applicability of this comand cholesterol in a molar ratio of 1:1 increased the in pound for both systemic and local administrations. Furvivo transfer of a reporter gene. 17 Our cationic liposome thermore, tumor cells treated with liposomal-encapsuformulation (PC/CHOL/DDAB) has several advantages. lated antisense raf oligo were radiosensitive compared Based on our previous experience (PG and AR), we reawith control cells (Table 1) . More recently, in collaborsoned that the presence of phosphatidylcholine should ation with Dr Brett Monia (ISIS Pharmaceuticals, facilitate the encapsulation of oligos within the bilayered Carlsbad, CA, USA), experiments have been initiated to lipid vesicles. Cholesterol was included in this formudemonstrate the radiosensitizing effect of liposomelation because the presence of at least 25 mole percentage encapsulated antisense raf oligo (5132) 30 in the SQ-20B of cholesterol in liposomes has been shown to increase tumor xenograft model. The in vivo data obtained so far their stability and retention in the circulation. 37 The in athymic mice are promising (Gokhale et al, unpub-PC/CHOL/DDAB liposomal formulation was found to lished data). The present observations imply that liposobe nontoxic, and yielded a high ODN encapsulation mal delivery of ATG-AS raf ODN in combination with efficiency.
LE-ATG-AS raf ODN (AS), or 10 m LE-ATG-S raf ODN (S) for
radiation may be an effective gene-targeting approach for We have identified several in vivo parameters that sugtreatment of cancers that are resistant to standard radigest the potential use of these cationic liposomes as a suitable vehicle to transport antisense oligos safely and ation therapy.
Figure 7 Effects of intravenous administration of LE-ATG-AS raf ODN on Raf-1 expression in normal and tumor tissues. Raf-1 expression was examined in liver, kidneys and SQ-20B tumor xenograft of Balb/c nu/nu mice after i.v. injections of 6 mg/kg daily dose of LE-ATG-AS raf ODN (AS) or LE-ATG-S raf ODN (S) for 5 consecutive days. Control mice (C) received normal saline. Representative data showing Raf-1 expression in lysates normalized for protein content by immunoprecipitation and immunoblotting (top). Quantification data are shown as mean ± s.d. from three mice (bottom).
Materials and methods
Oligodeoxyribonucleotides
Oligodeoxyribonucleotide sequences directed toward the translation initiation site of human c-raf-1 cDNA were synthesized at Lofstrand Labs Limited (Gaithersburg, MD, USA) using beta-cyanoethyl phosphoramidite chemistry on a Biosearch 8750 DNA synthesizer. The sense (ATG-S) and antisense (ATG-AS) raf ODN sequences were 5′-GCAT-CAATGGAGCAC-3′ and 5′-GTG-CTCCATTGATGC-3′, respectively. One terminal base linkage at each end was modified to a phosphorothioate group using 3H-1,2-benzodithiole-3-1,1,1-dioxide as the sulfurizing agent. Oligos were synthesized at the 15 m scale and purified on reverse phase chromatography columns. For quality control, a small aliquot of each oligo preparation was 32 P-end-labeled and visualized by polyacrylamide gel electrophoresis (20% acrylamide and 5% bis) followed by densitometric scanning of the labeled products.
For synthesis of the 5′-fluorescein-labeled ATG-AS/S cycles. The coupling consisted of the simultaneous addition of, and 15 min incubation with 0.25 ml of a 0.1 (FBS), 2 mm glutamine, 0.1 mm nonessential amino acids, 0.4 g/ml hydrocortisone, 100 g/ml streptomycin and m solution of fluorescein amidite in acetonitrile and 0.25 ml of a 0.45 m solution of tetrazole in acetonitrile. After 100 U/ml penicillin. synthesis, the ODNs were deprotected and cleaved from the support in 1.0 ml 30% ammonium hydroxide for Intracellular raf ODN uptake and stability assays Logarithmically growing SQ-20B cells were seeded into 24 h at room temperature. During deprotection, the fluorescein labels were modified to the same structure as six-well plates (1 × 10 6 cells per well) in 20% FBS containing medium. The next day, cells were switched to 1% FBS when prepared using fluorescein isothiocyanate (FITC). Purification was performed using standard reverse phase containing medium and incubated at 37°C with 10 m 32 P-labeled LE-ATG-AS raf ODN or ATG-AS raf ODN chromatography cartridges. The purified ODNs were eluted from the cartridges in 1.0 ml 20% acetonitrile,
(1 × 10 6 c.p.m./ml). Following incubation for various intervals, cells were washed with PBS, trypsinized and dried and resuspended in water.
centrifuged. The cell pellet was rinsed twice with PBS, resuspended in 0.2 m glycine (pH 2.8) and then washed Preparation of cationic liposomes Cationic lipids, 1,2-dioleoyl-3-trimethyl ammonium proagain with PBS. This treatment strips off the membranebound ODN, and the remaining radioactivity was interpane (DOTAP), 1,2-dimyristoyl-3-trimethyl ammonium propane (DMTAP), and dimethyldioctadecyl ammonium preted as representative of the intracellular level of ODN. The cell pellet was then lysed in 1% SDS and the intrabromide (DDAB) were purchased from Avanti Polar Lipids (Alabaster, AL, USA). Blank liposomes were prepared cellular radioactivity was determined by liquid scintillation counting. using one of the three cationic lipids, phosphatidylcholine (PC) and cholesterol (CHOL) in a molar ratio of For ODN stability studies, cells were seeded and incubated with 10 m 32 P-labeled LE-ATG-AS raf ODN or 1:3.2:1.6. LE-ATG-S and LE-ATG-AS raf ODNs were prepared using DDAB, PC and CHOL in a molar ratio of ATG-AS raf ODN (1 × 10 6 c.p.m./ml) for 4 h at 37°C in 1% FBS containing medium. Following this initial incubation 1:3.2:1.6. Briefly, the lipids dissolved in chloroform or methanol were evaporated to dryness in a round-botwith ODN, cells were washed three times with PBS and switched to 20% FBS containing medium. Incubations tomed flask using a rotatory vacuum evaporator. The dried lipid film was hydrated overnight at 4°C by adding continued for various times, followed by trypsinization and washing with PBS. The cell pellets were lysed in 10 1 ml of ODN at 1.0 mg/ml in phosphate-buffered saline (PBS). The film was dispersed by vigorous vortexing and mm Tris-HCl, 200 mm NaCl, 1% SDS, 200 g/ml proteinase K, pH 7.4 for 2 h at 37°C. ODNs were extracted with the liposome suspension was sonicated for 5 min in a bath type sonicator (Laboratory Supplies, Hicksville, NY, phenol:chloroform, and the aqueous fractions were collected and aliquots were analyzed by scintillation coun-USA). The ODN to lipid ratio was 30 g ODN/mg of lipid. The unencapsulated ODN was removed by washting. The samples were normalized for equal radioactivity in order to correct for a possible ODN efflux over ing the liposomes and centrifugation three times at 75 000 g for 30 min in PBS. The ODN encapsulation efficiency time, followed by electrophoresis in a 15% polyacrylamide/7 m urea gel, and autoradiography. was determined by scintillation counting of an aliquot of the preparation in which traces of 32 P-end-labeled ODN were added to an excess of the unlabeled ODN. The lipoPharmacological disposition studies of raf ODN Male Balb/c nu/nu mice (Charles River, Raleigh, NC, some-encapsulated ODNs were stored at 4°C and used within 2 weeks of preparation. Blank liposomes were pre-USA; 10-12 weeks old) were maintained in the Research Resources Facility of the Georgetown University accordpared exactly as described above in the absence of ODN.
ing to accredited procedure, and fed purina chow and water ad libitum. Mice were injected intravenously via the Cell culture SQ-20B tumor cells were established from a laryngeal tail vein with 30 mg/kg of LE-ATG-AS raf ODN or ATG-AS raf ODN. At 5 min, 15 min, 30 min, 1 h, 2 h, 4 h, squamous cell carcinoma of a patient who had failed a full course of radiation therapy. 43 Tumor cells were 8 h, 24 h and 48 h after injection, one animal in each group was bled from the retro-orbital sinus into hepgrown as monolayers in Dulbecco's modified Eagle's medium (GIBCO BRL, Grand Island, NY, USA) suparinized tubes under anesthesia, and killed by cervical dislocation. The blood was centrifuged immediately at plemented with 20% heat inactivated fetal bovine serum 300 g for 10 min at 4°C to separate the plasma. The liver, Raf-1 using protein A-agarose conjugated rabbit polyclonal antibody against 12 carboxy terminal amino acids kidneys, spleen, heart and lungs were rapidly excised and rinsed in ice-cold normal saline. The plasma and of human Raf-1 p74 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The immunoprecipitates were sequenorgans were stored at −70°C until further analysis.
Antisense raf ODN was isolated from plasma samples tially washed with cell lysis buffer, 0.5 m LiCl 100 mm Tris-HCl, pH 7.4, and 10 mm Tris-HCl, pH 7.4. The using the phenol-chloroform extraction method, and from tissues using a DNA extraction kit (Stratagene, La immune complexes were boiled in Laemmli sample buffer and resolved by 7.5% SDS-PAGE, followed by Jolla, CA, USA). The raf ODN concentration standards were prepared by adding known amounts of ATG-AS raf immunoblotting with polyclonal anti-Raf-1 antibody and detection of Raf-1 using ECL reagents according to the ODN in blank plasma or blank tissue samples, followed by extraction as mentioned above. The extracts were manufacturer's protocol (Amersham Corporation, Arlington Heights, IL, USA). Raf-1 protein expression loaded on to 20% polyacrylamide/8 m urea gels and electrophoresed in TBE buffer. The gels were electroblotted was quantified using the computer software program (Image-Quant; Molecular Dynamics, USA). on to nylon membranes in 0.5 × TBE buffer at 20 V for 1 h, and the blots were probed with 32 P-labeled sense For in vivo expression studies, tumor tissue and organs were homogenized in the cell lysis buffer using Polytron probe (ATG-S raf ODN) in Quickhyb buffer (Stratagene) at 30°C overnight. The radiolabeled probe was generated homogenizer (Westbury, NY, USA). Raf-1 expression was analyzed in tissue homogenates by immunoprecipitation by 5′-end-labeling of ATG-S raf ODN with ␥-32 P-ATP using T4 polynucleotide kinase and purification over and immunoblotting as described above. Chroma Spin-10 columns (Clontech, Palo Alto, CA, USA). A 10-to 50-fold excess of the probe was used to ensure
Raf-1 protein kinase activity assay Logarithmically growing SQ-20B cells were treated with saturation of all bands. The autoradiographs were scanned using a computer program (ImageQuant 10 m LE-ATG-AS raf ODN, LE-ATG-S raf ODN or blank liposomes for 8 h in 1% FBS containing medium. Cells software, Molecular Dynamics, Sunnyvale, CA, USA), and the amounts of ATG-AS raf ODN in various samples were lysed as described above, and lysates, normalized for protein content, were immunoprecipitated with agawere calculated by comparison to standards.
rose-conjugated anti-Raf-1 antibody overnight at 4°C. Raf-1 phosphotransferase activity was assayed in vitro In vivo delivery of S/AS raf ODN Logarithmically growing SQ-20B cells were injected subusing its physiological substrate, mitogen-activated protein kinase kinase (MKK1) 32 in kinase buffer containing cutaneously (2 × 10 6 cells) in the flank regions on both sides in male Balb/c nu/nu mice under mild anesthesia.
30 mm Hepes (pH 7.4), 1 mm manganese chloride, 1 mm DTT, 0.1 mm ATP, and 20 Ci [- 32 P]ATP (6000 Tumors were allowed to grow to a mean tumor volume of 115 mm 3 before initiation of ODN treatment. Two Ci/mmol) as described before. 21 Radiolabeled reaction products were separated by 10% SDS-PAGE and autotreatment routes were followed: intravenous and intratumoral. For intravenous delivery, mice were randomly radiographed. The MKK1 bands were quantified using the Image-Quant program (Molecular Dynamics). divided into six groups. Three mice in each group received LE-ATG-AS, LE-ATG-S, ATG-AS, ATG-S, blank liposomes or normal saline intravenously by bolus Radiation survival dose response assay The appropriate numbers of SQ-20B cells were seeded in infusion via tail vein at a dose of 6 mg/kg daily for 5 days. Mice were killed 24 h after the last treatment, and duplicate T-25 tissue culture flasks (Corning, NY, USA) in medium containing 20% FBS, and allowed to attach the organs and tumor tissue were rapidly excised, rinsed in ice-cold normal saline and stored at −70°C.
for 8 h at 37°C. The medium was replaced with medium containing 1% FBS and the cells were exposed to 10 m For intratumoral delivery, mice were randomly divided into three groups. Three mice in one group received LE-ATG-AS raf ODN, 10 m LE-ATG-S raf ODN or 10 m blank liposomes for 6 h before irradiation. intratumoral injections of 4 mg/kg LE-ATG-AS raf ODN on the right flank, and LE-ATG-S raf ODN on the left Irradiations were performed using 137 Cs gamma irradiator (JL Shepard MARK I irradiator) and a dose rate of flank, daily for 7 days. Two control groups, three mice per group, received normal saline or blank liposomes.
114 cGy/min. The cells were irradiated with total doses of 1 Gy, 3 Gy, 5 Gy and 13 Gy, followed by incubation Mice were killed 24 h after the last treatment, and the tumor tissue was excised, rapidly rinsed in ice-cold norfor 2 h. The medium in all flasks was then replaced with 20% FBS containing medium and incubations continued mal saline and stored at −70°C.
for 7-10 days. Surviving colonies were fixed and stained with 0.5% methylene blue and 0.13% carbol fuchsin in Raf-1 immunoprecipitation and immunoblotting assays For in vitro experiments, logarithmically growing SQ-20B methanol. Colonies containing 50 or more cells were scored and data were fitted to the computer-generated cells were exposed to LE-ATG-AS raf ODN, LE-ATG-S raf ODN or blank liposomes for various doses and time single-hit multitarget and linear-quadratic models of radiation survival response. 44 intervals in 1% FBS containing medium. Following incubation, cells were lysed in the buffer containing 500 mm Hepes (pH 7.2), 1% NP-40, 10% glycerol, 5 mm sodium
